ON 123300 (Narazaciclib) and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma

Conditions: Relapsed and/or Refractory Multiple Myeloma Interventions: Drug: ON 123300; Drug: Dexamethasone Sponsors: Adriana Rossi Not yet recruiting

https://clinicaltrials.gov/study/NCT06351644

Source: ClinicalTrials.gov - April 8, 2024 Category: Research Source Type: clinical trials

More News: Dexamethasone | Myeloma | Research